Literature DB >> 34843014

Multi-parametric evaluation of ocular surface disorders during healing process of viral conjunctivitis.

Gozde Sahin Vural1, Ozlem Barut Selver2, Ali Veral3, Melis Palamar2.   

Abstract

Purpose To evaluate the ocular surface properties in epidemic keratoconjunctivitis (EKC) patients during healing process, and to detect the damage on conjunctival goblet cells. Methods Bilateral EKC patients confirmed with polymerase chain reaction (PCR) testing were included. Firstly (Group 1) and secondly (Group 2) affected eyes were compared. Ocular surface parameters were performed at the first visit and first month. Results The study included 34 eyes of 17 patients. The mean age was 44.54 ± 16.80 (21-70) years (FM/M 20/14). The ocular findings in Groups 1 and 2 were not significant. For Groups 1 and 2, OSDI was 53.53 ± 23.01 and 35.90 ± 22.19 (p 0.03), tear osmolarity was 309.12 ± 19.38 and 297.47 ± 8.27 mOsm/µL (p 0.029), OSSS was 1.00 ± 0.79 and 0.18 ± 0.39 (p 0.001), T-BUT was 3.59 ± 2.29 and 6.00 ± 1.83 s (p 0.002), and Schirmer's 1 test was 10.94 ± 8.42 and 16.76 ± 9.05 mm (p 0.061), respectively. In Groups 1 and 2, the IC was Grade (G) 0 in 23.5% and 17.6%, G1 in 35.3% and 41.2%, and G2 in 41.2% and 41.2%, respectively. The ocular surface properties were worse in Group 1 than Group 2, and the difference was significant except for Schirmer's 1 test and IC. Conclusions Dry eye disorder is a complication of EKC and may cause a significant decrease in quality of life.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Adenovirus; Dry eye disorder; Epidemic keratoconjunctivitis; Viral conjunctivitis

Mesh:

Year:  2021        PMID: 34843014     DOI: 10.1007/s10792-021-02130-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  23 in total

Review 1.  Grading of corneal and conjunctival staining in the context of other dry eye tests.

Authors:  Anthony J Bron; Victoria E Evans; Janine A Smith
Journal:  Cornea       Date:  2003-10       Impact factor: 2.651

2.  Adenoviral keratoconjunctivitis in a tertiary care eye clinic.

Authors:  Amir Latif Butt; James Chodosh
Journal:  Cornea       Date:  2006-02       Impact factor: 2.651

Review 3.  Adenovirus advances: new diagnostic and therapeutic options.

Authors:  Herbert E Kaufman
Journal:  Curr Opin Ophthalmol       Date:  2011-07       Impact factor: 3.761

4.  Adenovirus type 8 keratoconjunctivitis in the United States. 3. Epidemiologic, clinical, and microbiologic features.

Authors:  C R Dawson; L Hanna; T R Wood; R Despain
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

5.  Laboratory studies in acute conjunctivitis.

Authors:  S Stenson; R Newman; H Fedukowicz
Journal:  Arch Ophthalmol       Date:  1982-08

6.  Assessment of clinical signs associated with adenoviral epidemic keratoconjunctivitis cases in southern Japan between 2011 and 2014.

Authors:  Koki Aoki; Gabriel Gonzalez; Rikutaro Hinokuma; Nobuyo Yawata; Masayuki Tsutsumi; Shigeaki Ohno; Nobuyoshi Kitaichi
Journal:  Diagn Microbiol Infect Dis       Date:  2019-08-07       Impact factor: 2.803

7.  Adenoviral keratoconjunctivitis.

Authors:  Alexander Bialasiewicz
Journal:  Sultan Qaboos Univ Med J       Date:  2007-04

8.  [Detection and Molecular Characterization of Human Adenoviruses from Acute Conjunctivitis Cases].

Authors:  Seda Tezcan Ülger; Aslıhan Bekçi; Ayça Yılmaz; Gönül Aslan
Journal:  Mikrobiyol Bul       Date:  2019-07       Impact factor: 0.622

9.  Correlation between corneal involvement and anterior chamber flare in epidemic keratoconjunctivitis.

Authors:  Pelin Kiyat; Melis Palamar; Suzan Guven Yilmaz; Sinan Emre
Journal:  Eur J Ophthalmol       Date:  2019-05-21       Impact factor: 2.597

Review 10.  Acute conjunctivitis: truth and misconceptions.

Authors:  Terrence P O'Brien; Bennie H Jeng; Marguerite McDonald; Michael B Raizman
Journal:  Curr Med Res Opin       Date:  2009-08       Impact factor: 2.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.